Qiang Zhao

Qiang Zhao

Auto-generated profile, based on publicly available information

Qiang Zhao

Department of Dermatology, Northwest Hospital, The Second Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TZTong Zhou
Tong Zhou
YFYuqing Feng
Yuqing Feng
DCDelu Che
Delu Che
CYCong Yan
Cong Yan
ZCZhaowei Chu
Zhaowei Chu
SGSongmei Geng
Songmei Geng

1 September 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
QZQiang Zhao
Qiang Zhao
HZHongmei Zhou
Hongmei Zhou
SGSongmei Geng
Songmei Geng

30 August 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
JHJiahui Hu
Jiahui Hu
XZXinyue Zhang
Xinyue Zhang
LZLihong Zhao
Lihong Zhao
QZQiang Zhao
Qiang Zhao
SGSongmei Geng
Songmei Geng
Primary cutaneous CD4+ small/medium-sized pleomorphic T-Cell lymphoproliferative disorder (PC-SMTLD) has been considered as a controversial dermatological disease that has been included in cutaneous T-cell lymphoma group, presenting most commonly as a solitary nodule and/or plaque with a specific and characteristic head and neck predilection. Due to the considerable overlap between PC-SMTLD and pseudolymphoma (PL), the differential diagnosis is often challenging. Methylation of DNA at position 5 of cytosine, and the subsequent reduction in intracellular 5-hydroxymethylcytosine (5-hmC) levels, is a key epigenetic event in several cancers, including systemic lymphomas. However, it has rarely been studied in cutaneous lymphomas. The authors aimed to explore the role of differential 5-hmC immunostaining as a useful marker to distinguish PC-SMTLD from PL. Retrospective case series study with immunohistochemical and immunofluorescence analysis of 5-hmC was performed in PL and PC-SMTLD. Significant decrease of 5-hmC nuclear staining was observed in PC-SMTLD when compared with PL (p < 0.0001). By semi-quantitative grade integration, there were statistical differences in the final 5-hmC scores in the two study groups. The IF co-staining of 5-hmC with CD4 revealed a decrease of 5-hmC in CD4+ lymphocytes of PC-SMTLD. The small clinical sample size of the study. The immunorreactivity of 5-hmC in CD4+ lymphocytes was highly suggestive of a benign process as PL. Furthermore, the decrease of 5-hmC nuclear staining in PC-SMTLD indicated its lymphoproliferative status and helped to make the differential diagnosis with PL.

1 September 2019 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
QZQiang Zhao
Qiang Zhao
HZHongmei Zhou
Hongmei Zhou
SGSongmei Geng
Songmei Geng

1 January 2024 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
JHJiahui Hu
Jiahui Hu
XZXinyue Zhang
Xinyue Zhang
LZLihong Zhao
Lihong Zhao
QZQiang Zhao
Qiang Zhao
SGSongmei Geng
Songmei Geng